Colinz Laboratories Performance
- Today's Low
- ₹78
- Today's High
- ₹86
- 52 Week Low
- ₹36
- 52 Week High
- ₹88
- Open Price₹82
- Previous Close₹82
- Volume6,492
- 50 DMA₹64.30
- 100 DMA₹58.20
- 200 DMA₹54.00
Colinz Laboratories Chart
Investment Returns
- Over 1 Month + 38.2%
- Over 3 Month + 68.41%
- Over 6 Month + 68.09%
- Over 1 Year + 73.12%
Smart Investing Starts Here Start SIP with Colinz Laboratories for Steady Growth!
Colinz Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 39.4
- PEG Ratio
- 10.9
- Market Cap Cr
- 20
- P/B Ratio
- 2
- Average True Range
- 4.8
- EPS
- 2
- Dividend Yield
- 0
- MACD Signal
- 4.4
- RSI
- 60.36
- MFI
- 88.84
Latest Stock News Updates
Dear Sir, As required under under SEBI Regulation 2015, Please find the attached intimation towards closure of Trading form 1-7-2026 till the 48 hours of the Issue of Quarterly results as on 30-6-2026. Kindly take the same on records. For Colinz Labs Ltd Director
- BSE India
- 3 days 3 hours ago
Dear Sir, Please find the attached Certificate issued by our RTA Bigshare Services Pvt Ltd. for the Quarter ended on 30-6-2026 as required under regulation 74(5). Kindly tahe the same o records. for Colinz Labs Ltd Director
- BSE India
- 1 week 3 days ago
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer ("DLOF") for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target Company").
- BSE India
- 1 week 6 days ago
Colinz Laboratories Financials
Colinz Laboratories Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹72.30
- 50 Day
- ₹64.30
- 100 Day
- ₹58.20
- 200 Day
- ₹54.00
Resistance and Support
- R3 91.00
- R2 88.40
- R1 83.20
- S1 75.40
- S2 72.80
- S3 67.70
Colinz Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-04-29 | Quarterly Results | |
| 2026-01-24 | Quarterly Results | |
| 2026-01-17 | Others | |
| 2025-11-27 | Others | Inter-alia to approve appointment of Ms. Falguni Kumawat as the Company Secretary and Compliance Officer of the Company and Key Managerial Personnel of the Company. |
| 2025-11-11 | Others | Inter-alia, to approve appointment of Smt. Vijaya Mani (DIN 11363910) as Additional (Non- Executive) Director of the Company. |
About Colinz Laboratories
Colinz Laboratories is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynaecological sector. View More- NSE Symbol
- COLINZ
- BSE Symbol
- 531210
- ISIN
- INE923C01011
Similar Stocks to Colinz Laboratories
Popular Stocks
Colinz Laboratories FAQs
Colinz Laboratories share price is ₹80 As on 17 July, 2026 | 20:02
The Market Cap of Colinz Laboratories is ₹20.3 Cr As on 17 July, 2026 | 20:02
The P/E ratio of Colinz Laboratories is 39.4 As on 17 July, 2026 | 20:02
The PB ratio of Colinz Laboratories is 2 As on 17 July, 2026 | 20:02
The 52 week High & Low of Colinz Laboratories is ₹87.9/₹36.1 respectively As on 17 July, 2026 | 20:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.